| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee4ec9aab04875f57f24dafc0df46d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65705dca71d48b681c3aeb098ccd6291 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2007-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67b43dae356e2f4f0c05ae8c0d53070f |
| publicationDate |
2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008015252-A1 |
| titleOfInvention |
Therapeutic agent for virus-associated malignancy |
| abstract |
A therapeutic agent comprising fucoxanthin or fucoxanthinol as an active component is disclosed. The therapeutic agent is effective and high clinical utility for medical treatment and prevention of virus-associated malignancy such as adult T-cell leukemia and Burkitt lymphoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2345409-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015136123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2918278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2345409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011172185-A1 |
| priorityDate |
2006-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |